Toxic shock due to Streptococcus pyogenes in a rhesus monkey (Macaca mulatta)

Journal of the American Association for Laboratory Animal Science

Volumn 45, Issue 5, 2006, Pages 79-82

  García, Anapatricia ^a   Paul, Katherine ^a   Beall, Bernard ^b   McClure, Harold ^a  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; ENROFLOXACIN; M PROTEIN; PYROGEN; RINGER LACTATE SOLUTION; SUPERANTIGEN; TYLOSIN;

ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; FEMALE; FEVER; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARYNGITIS; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SEPTIC SHOCK; SKIN MANIFESTATION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMALS; FATAL OUTCOME; FEMALE; MACACA MULATTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ANIMALIA; MACACA MULATTA; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 33749125455     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Beall B, Gherardi G, Lovgren M, Facklam RR, Forwick BA, Tyrrell GJ. 2000. emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology 146:1195-1209.
2. Centers for Disease Control and Prevention [Internet]. Group A streptococcal (GAS) disease [cited 6 Oct 2005]. Available at www.cdc.gov/ncidod/strep/protocol.htm
3. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470-511.
4. Efstratiou A. 2000. Group A streptococci in the 1990s. J Antimicrob Chem 45:3-12.
5. Jarva H, Jokiranta TS, Wuzner R, Meri S. 2003. Complement resistance mechanisms of streptococci. Mol Immunol 40:95-107.
6. Kim SW, Grant JE, Kim SI, Swanson TA, Bernstein GA, Jaszcz WB, Williams KA, Schlievert PM. 2004. A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 16:252-260.
7. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB. 2005. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41:1114-1122.
8. Mohan C, Ganguly NK, Chakravarti RN. 1987. Experimental production of cardiac injury in rhesus monkeys by L-forms of group-A streptococci. Indian J Med Res 86:361-371.
9. Mohan C, Ganguly NK, Chakravarti RN, Chitkan NL. 1977. Prevalence of haemolytic streptococcal infection in rhesus monkey. J Hygiene Epidem Microbiol Immunol 2:203-208.
10. Nandi S, Chakraborti DK, Bakshi DK, Rani A, Kumar R, Ganguly NK. 2002. Association of pyogenic exotoxin genes with pharyngitis and rheumatic fever/rheumatic heart disease among Indian isolates of Streptococcus pyogenes. Lett Appl Microb 35:237-241.
11. Ooe K, Udagawa H. 1997. A new type of fulminant group A streptococcal infection in obstetric patients: report of two cases. Human Pathol 28:509-512.
12. Stollerman GH. 2001. Rheumatic fever in the 21st century. Clin Infect Dis 15:806-814.
13. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55.